Eli Lilly and Company (LLY)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	5,240,400	4,988,400	6,497,500	5,686,800	6,244,800	6,033,200	5,691,600	6,129,300	5,581,700	5,972,400	6,070,700	6,092,500	6,193,700	5,572,600	5,618,100	5,533,300	8,318,400	7,947,700	7,843,300	6,256,200
Revenue (ttm)	US$ in thousands	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100	22,319,500	21,843,100	21,673,400	21,621,700
Net profit margin		15.36%	15.55%	22.01%	20.54%	21.88%	20.63%	19.58%	20.90%	19.71%	21.52%	22.71%	23.91%	25.24%	24.01%	24.48%	23.97%	37.27%	36.39%	36.19%	28.93%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $5,240,400K ÷ $34,124,100K
= 15.36%

Lilly(Eli) & Co's net profit margin has exhibited fluctuation over the past eight quarters. The company's net profit margin ranged from a low of 15.36% in Q4 2023 to a high of 22.01% in Q2 2023, indicating variability in profitability. Despite some ups and downs, the overall trend shows relative stability in the net profit margin over the period analyzed. It is noteworthy that the net profit margin in Q4 2023 was slightly lower than the previous quarter, Q3 2023, which may suggest a potential dip in profitability during that period. However, further analysis would be required to understand the factors contributing to these fluctuations and their implications for the company's financial performance.